Robert Charmak, right, works with fellow traders on the floor of the New York Stock Exchange, Wednesday, June 10, 2015. The Dow jumped more than 1.3 percent Wednesday as a broad-based rally led by technology and banking shares snapped a week of anemic trade in US equity markets. AP PHOTO/RICHARD DREW
NEW YORK–The Dow jumped more than 1.3 percent Wednesday as a broad-based rally led by technology and banking shares snapped a week of anemic trade in US equity markets.
The Dow Jones Industrial Average surged 236.36 points (1.33 percent) to 18,000.40.
The broad-based S&P 500 rose 25.05 (1.20 percent) to 2,105.20, while the tech-rich Nasdaq Composite Index gained 62.82 (1.25 percent) to 5,076.69.
Stocks were helped by midday news that German Chancellor Angela Merkel and French President Francois Hollande would meet with Greek Prime Minister Alexis Tsipras on the sidelines of an EU-Latin America summit, encouraging hopes for a deal extending Greece’s bailout funding.
But analysts attributed the strong gains primarily to a rally after four straight days of either negative or flat trade.
“You’re seeing buyers step in and take advantage of a market that has been under pressure during the last trading days,” said David Levy, portfolio manager at Kenjol Capital Management.
“It’s a relief rally on oversold conditions.”
Large technology stocks were especially strong, with Dow member Microsoft gaining 2.1 percent and Facebook and Google both rising 1.9 percent. Apple rose 1.2 percent.
Banking shares also thrived. Dow members JPMorgan Chase and Goldman Sachs jumped 1.6 percent and 2.0 percent, while Bank of America added 1.6 percent.
Petroleum-linked shares rose in tandem with oil prices. Anadarko gained 1.7 percent, ConocoPhillips added 1.5 percent and Halliburton surged 2.1 percent.
Netflix bolted 3.7 percent higher after shareholders approved a measure to increase the company’s share count, a step that is expected to lead to a stock split.
Johnson Controls, which specializes in energy efficiency products for buildings and autos, surged 3.9 percent after announcing a strategic review of its auto business that could result in a sale of the division. Johnson said it enlisted Goldman Sachs and Centerview Partners to serve as financial advisors.
Regeneron Pharmaceuticals fell 2.6 percent after an FDA advisory committee approved its Praluent treatment for lowering cholesterol. However, the approval was “not as clean and positive as expectations” as committee members “seemed hung up” on the lack of outcomes data and the safety of the medicine, said a note from RBC Capital Markets.
Bond prices fell. The yield on the 10-year US Treasury rose to 2.49 percent from 2.43 percent Tuesday, while the 30-year advanced to 3.21 percent from 3.16 percent. Bond prices and yields move inversely.